Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sophia Dobischok"'
Autor:
Sophia Dobischok, José R. Carvajal, Kyle Turner, Kaitlyn Jaffe, Eisha Lehal, Sarinn Blawatt, Casey Redquest, Rosalind Baltzer Turje, Patrick McDougall, Bryce Koch, Cheryl McDermid, Damon Hassan, Scott Harrison, Eugenia Oviedo-Joekes
Publikováno v:
Addiction Science & Clinical Practice, Vol 18, Iss 1, Pp 1-12 (2023)
Abstract Background Injectable opioid agonist treatment (iOAT) has proven to be a safe and effective treatment option for severe opioid use disorder (OUD). Yet, iOAT is often isolated from other health and social services. To align with a person-cent
Externí odkaz:
https://doaj.org/article/90112e20fdde4163bbe43f8f60b330bc
Autor:
Eugenia Oviedo-Joekes, Sophia Dobischok, José Carvajal, Scott MacDonald, Cheryl McDermid, Piotr Klakowicz, Scott Harrison, Julie LaJeunesse, Nancy Chow, Murray Brown, Sam Gill, Martin Schechter
Publikováno v:
BMC Health Services Research, Vol 23, Iss 1, Pp 1-16 (2023)
Abstract Background To support public health measures during the COVID-19 pandemic, oral opioid agonist treatment (OAT) take-home doses were expanded in Western countries with positive results. Injectable OAT (iOAT) take-home doses were previously no
Externí odkaz:
https://doaj.org/article/14e0a94ee7f845998ae903bab0a1c171
Autor:
Eugenia Oviedo-Joekes, Sophia Dobischok, José Carvajal, Scott MacDonald, Cheryl McDermid, Piotr Klakowicz, Scott Harrison, Julie Lajeunesse, Nancy Chow, Murray Brown, Sam Gill, Martin Schechter
Background To support public health measures during the Covid-19 pandemic, oral opioid agonist treatment (OAT) take-home doses were expanded in Western countries with positive results. Injectable OAT (iOAT) take-home doses, which were previously not
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5436991ff2d7e731858e8e86552005a
https://doi.org/10.21203/rs.3.rs-2570581/v1
https://doi.org/10.21203/rs.3.rs-2570581/v1
Autor:
Sophia Dobischok, Rebecca K Metcalfe, Elizabeth Angela Matzinger, Kurt Lock, Scott Harrison, Scott MacDonald, Sherif Amara, Martin T Schechter, Nick Bansback, Eugenia Oviedo-Joekes
Publikováno v:
Patient preference and adherence. 16
Sophia Dobischok,1 Rebecca K Metcalfe,1 Elizabeth Angela Matzinger,1 Kurt Lock,1,2 Scott Harrison,3 Scott MacDonald,3 Sherif Amara,4 Martin T Schechter,1,5 Nick Bansback,1,5 Eugenia Oviedo-Joekes1,5 1Centre for Health Evaluation & Outcome Sciences, P
Autor:
Sophia Dobischok, Rebecca Metcalfe, Elizabeth Matzinger, Heather Palis, Kirsten Marchand, Scott Harrison, Scott MacDonald, David Byres, Martin Schechter, Nick Bansback, Eugenia Oviedo-Joekes
Publikováno v:
The International journal on drug policy. 112
Injectable opioid agonist treatment (iOAT) is effective for opioid use disorder (OUD), yet little is known about client preferences for accessing iOAT (e.g., with diacetylmorphine, hydromorphone, buprenorphine, fentanyl, etc.). Best-worst scaling (BW
Autor:
Erielle Dizon, Rachel Sargeant, Kelly Pei Xuan Chia, Nimrit Basra, Nicky Didicher, Sophia Dobischok, Justin Bermudez, Students in Engl, pkpadmin, Lily Nichol, Natasha Tar
In Our Reading Roots, the participants in English 487 Topics in Children's Literature in Summer 2021 at Simon Fraser University share stories of becoming readers, relationships with libraries and librarians, family reading time, social struggles, com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aff65020946f39d649eccf8432fbae25
https://doi.org/10.21810/sfulibrary.89
https://doi.org/10.21810/sfulibrary.89
Autor:
Sophia Dobischok
Publikováno v:
Our Reading Roots
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10da2d75bddda0e3a2b11bfb63a29fb2
https://doi.org/10.21810/sfulibrary.89.2371
https://doi.org/10.21810/sfulibrary.89.2371